FIGS(US:FIGS)2025-08-07 22:00Financial Data and Key Metrics Changes - Net revenues increased by 6% year-over-year to $152.6 million, exceeding expectations of flat performance for the period [26][27] - Adjusted EBITDA margin improved by 390 basis points year-over-year to 12.9% [10][31] - Net income for the quarter was $7.1 million, or diluted EPS of $0.04, compared to net income of $1.1 million, or diluted EPS of $0.01, last year [31] Business Line Data and Key Metrics Changes - Scrub wear category grew by 8%, representing 83% of net revenues for the period [27][28] - Non-scrub wear decreased by 3%, representing 17% of net revenues, impacted by a pullback in promotional strategy [28] - Average Order Value (AOV) increased by 4% to $117, driven by higher average unit retail due to product mix and lower return rates [27][44] Market Data and Key Metrics Changes - U.S. sales increased by 4% to $129.9 million, marking the strongest performance in nearly two years [29] - International net revenues increased by 20%, with strong growth in new and existing customers [29] - Active customers increased by 4% year-over-year to 2.7 million [27] Company Strategy and Development Direction - The company is focusing on serving healthcare professionals and enhancing brand differentiation through impactful marketing and product innovation [12][19] - Strategic repositioning away from broader promotional periods aims to drive productivity and intentionality in business operations [6][11] - Expansion into international markets, including recent launches in Japan and planned entry into South Korea, is part of the growth strategy [19][20] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in sustaining momentum despite macroeconomic uncertainties and tariff impacts [10][11] - The outlook for fiscal 2025 has been improved, with net revenues now expected to grow low single digits year-over-year [11][35] - Management emphasized the importance of strategic investments and cost mitigation efforts to navigate the dynamic trade environment [10][11] Other Important Information - The company has a strong balance sheet with net cash and short-term investments of $238.8 million [31] - Inventory increased by 14% year-over-year to $135.5 million, reflecting higher average unit pricing due to product mix and modest tariff impacts [31][32] - The company is prioritizing investments in business growth over share repurchases, with $52 million available for future repurchases [33][90] Q&A Session Summary Question: Impact of AOV and Product Innovation - Management noted that AOV increased due to product mix and returning customers, with product innovation being a key driver [43][44][47] Question: Engagement with Customers and Pricing Strategy - Management highlighted the importance of product and marketing execution, stating that pricing changes will be a last resort after exploring other cost mitigation strategies [52][56][57] Question: Tariff Impact Quantification - Management quantified the tariff impact for 2025 at approximately 150 basis points, with ongoing efforts to mitigate this through sourcing and supplier negotiations [63][64][66] Question: Active Customers and Revenue Guidance - Management indicated that while active customer engagement is strong, the second half of the year will see a larger impact from promotional pullbacks [70][71] Question: Non-Scrub Wear Performance - Management acknowledged softness in non-scrub wear but emphasized long-term growth potential and plans for new product launches [85][86][88] Question: Share Repurchase Strategy - Management confirmed a focus on business growth investments over share repurchases, maintaining a conservative approach given market uncertainties [89][90]